AVITA Medical

AVITA Medical AVHHL Stock

$3.50   0.000000%
Add to favorites
Market Cap
$554.54M
LOW - HIGH [24H]
$3.50 - $3.50
VOLUME [24H]
$100.00
P/E Ratio
0
Earnings per share
-$0.23
ISIN
AU000000AVH4
Price   Prediction

AVITA Medical Price Chart

Sorry, that's all we've gotfor now...

AVITA Medical (AVHHL) stock price today is 3.5 USD on OTC Markets OTCPK (0% on the day). Updated .

AVITA Medical AVHHL Financial and Trading Overview

AVITA Medical stock price 3.5 USD
Previous Close 3.5 USD
Open 3.5 USD
Bid 2.41 USD x 90000
Ask 3.6 USD x 20000
Day's Range 3.5 - 3.5 USD
52 Week Range 0.56 - 3.5 USD
Volume 100 USD
Avg. Volume 420 USD
Market Cap 554.54M USD
Beta (5Y Monthly) 2.013
PE Ratio (TTM) N/A
EPS (TTM) -0.23 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

AVHHL Valuation Measures

Enterprise Value 146.6M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.548447
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.731
Enterprise Value/EBITDA -5.59

Trading Information

AVITA Medical Stock Price History

Beta (5Y Monthly) 2.013
52-Week Change 388.14%
S&P500 52-Week Change 10.51%
52 Week High 3.5 USD
52 Week Low 0.56 USD
50-Day Moving Average 2.48 USD
200-Day Moving Average 1.34 USD

AVHHL Share Statistics

Avg. Volume (3 month) 420 USD
Avg. Daily Volume (10-Days) 100 USD
Shares Outstanding 158.44M
Float 30.96M
Short Ratio N/A
% Held by Insiders 0.18%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:20

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -42.65%
Operating Margin (ttm) -33.88%
Gross Margin 82.36%
EBITDA Margin -30.96%

Management Effectiveness

Return on Assets (ttm) -32.45%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 84.68M USD
Revenue Per Share (ttm) 2.76 USD
Quarterly Revenue Growth (yoy) 53.10%
Gross Profit (ttm) 69.75M USD
EBITDA -26224000 USD
Net Income Avi to Common (ttm) -36117000 USD
Diluted EPS (ttm) -0.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 10.5M USD
Total Cash Per Share (mrq) 0.33 USD
Total Debt (mrq) 47.13M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.201
Book Value Per Share (mrq) -1.002

Cash Flow Statement

Operating Cash Flow (ttm) -19716000 USD
Levered Free Cash Flow (ttm) -8395875 USD

Profile of AVITA Medical

Country United States
State CA
City Valencia
Address 28159 Avenue Stanford
ZIP 91355
Phone 661 367 9170
Website https://avitamedical.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 226

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Q&A For AVITA Medical Stock

What is a current AVHHL stock price?

AVITA Medical AVHHL stock price today per share is 3.5 USD.

How to purchase AVITA Medical stock?

You can buy AVHHL shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for AVITA Medical?

The stock symbol or ticker of AVITA Medical is AVHHL.

Which industry does the AVITA Medical company belong to?

The AVITA Medical industry is Medical Devices.

How many shares does AVITA Medical have in circulation?

The max supply of AVITA Medical shares is 158.44M.

What is AVITA Medical Price to Earnings Ratio (PE Ratio)?

AVITA Medical PE Ratio is now.

What was AVITA Medical earnings per share over the trailing 12 months (TTM)?

AVITA Medical EPS is -0.23 USD over the trailing 12 months.

Which sector does the AVITA Medical company belong to?

The AVITA Medical sector is Healthcare.

$2.17T
Total marketcap
$69.7B
Total volume
BTC 58.08%   •   ETH 9.86%
Dominance
Select currency